E2020 SR 23 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E2020 SR 23 mg, covering 2014-08-01 to 2014-08-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia [Phase 2]